Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
BeOne Medicines
Genelux Corporation
Sun Yat-sen University
Boehringer Ingelheim
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
AstraZeneca
Merck Sharp & Dohme LLC
First Affiliated Hospital of Guangxi Medical University
Eastern Cooperative Oncology Group
AstraZeneca
AstraZeneca
AstraZeneca
Merck Sharp & Dohme LLC
Mirati Therapeutics Inc.
Merck Sharp & Dohme LLC
Eli Lilly and Company
Hoffmann-La Roche
AstraZeneca
Merck Sharp & Dohme LLC
Incyte Corporation
Merck Sharp & Dohme LLC
AstraZeneca
Bristol-Myers Squibb
Sun Yat-sen University
Hoffmann-La Roche
Eastern Cooperative Oncology Group
AstraZeneca
AstraZeneca
Alliance for Clinical Trials in Oncology
Affiliated Hospital of Guangdong Medical University
National Cancer Institute (NCI)
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
AstraZeneca
AstraZeneca
Bayer
Universität des Saarlandes
Eastern Cooperative Oncology Group
Children's Oncology Group
Children's Oncology Group
Jazz Pharmaceuticals
R-Pharm
UNICANCER